Hunan Huateng Pharmaceutical Co., Ltd, a global leader in PEG derivatives and Contract Development and Manufacturing Organization (CDMO) services, cordially invites you to visit our booth at CPhI Japan 2024, held from April 17th to 19th at Tokyo Big Sight, Tokyo, Japan. Event ...Learn More

Huateng Pharma, a distinguished provider of premium pharmaceutical intermediates, proudly unveils its latest breakthrough: Semaglutide Side Chain. This groundbreaking addition to Huateng Pharma's esteemed portfolio signifies a remarkable leap forward in pharmaceutical innovation, ...Learn More

Huateng Pharma, a Contract Development and Manufacturing Organization (CDMO) specializing in APIs and intermediates, is proud to announce its featured product line catering specifically to the veterinary industry. With a commitment to delivering high-quality solutions, Huateng ...Learn More

Huateng Pharma, a leading supplier of high-quality ingredients for the pharmaceutical and cosmetic industries, is proud to announce its range of novel ingredients designed for both commodities and cosmetics. The company is committed to delivering excellence from lab to commercial ...Learn More

Huateng Pharma proudly announces the launch of a groundbreaking suite of anti-diabetes intermediates, featuring key compounds such as Canagliflozin, Dapagliflozin, Empagliflozin, and Semaglutide. Emphasizing the potential impact on diabetes drug development, Huateng Pharma's ...Learn More